about
Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and CPD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 ExhaustionHeterologous T cell immunity in severe hepatitis C virus infectionEx vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinomaInterferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infectionIP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infectionDifferent clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune responseResponse prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma.Activation of natural killer cells during acute infection with hepatitis C virus.Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells.Comparative pathogenesis of HBV and HCV.Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infectionRole of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitisIs there a role for immunotherapy in hepatocellular carcinoma?Combination of radiofrequency ablation and immunotherapy.Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature.Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts.Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy.L-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of β-catenin-mutated human hepatocellular carcinoma cells.Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.Years of life that could be saved from prevention of hepatocellular carcinoma.HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).T cell regulation in HBV-related chronic liver disease.Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments.The evolutionary scenario of hepatocellular carcinoma in Italy: an update.Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes.Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment.Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma.
P50
Q27472920-180FED60-252C-46D0-8CC4-AE016BA05838Q27477628-573C37E4-2FA4-4FF0-BF67-15770F7F33ECQ27485208-5D57D51C-CE05-44EE-8225-02C76BC52FCDQ28191190-C53AB819-3C20-4839-BB4C-C42E8A0A3E6FQ28262594-525C59D2-7FE3-41C3-80B5-070542E7DB1BQ28276247-EA2A55D5-83E4-4A62-B380-09EF04420866Q29620891-0A04F814-0426-4B66-8B21-ABEA219989C7Q33842239-2D5C76AE-493B-4DE0-93BC-EA3230A17EF8Q34187221-DA183E0F-BF86-4E12-B468-EEB55BE705B4Q34283615-3AD841F3-61FC-4F33-A183-1879F49C4EB6Q34399693-B2CFE5A1-0207-41D5-8689-9E104796D1D7Q34556313-F5FD7CD4-E5D8-443E-A62C-6EE4DB20A7C6Q34599847-2CD8B211-5AEC-45DD-BDE2-F9F78B640A20Q35967086-E56CC82B-9D08-454F-B461-D6BAA8631B08Q36361411-1796597F-3E63-4D30-B58E-F277A7F123CEQ36388228-E2146906-A6BA-4022-B096-079C89112EE1Q36991803-B0465ED9-E7A4-48F7-A2E1-9F2001D15A20Q37716606-7B2B3112-8719-457B-ADCE-5427C71456D9Q38445623-59EAAC56-83BE-42F3-A86C-24455FD2F5D8Q38601494-53B1FC79-C119-4237-B454-778895B95C49Q38766239-3F17D062-FCBF-494A-9F25-8A7104330E13Q38773911-715C76D5-7B1F-4948-A3EC-824B5618C05BQ38964920-4319EF94-B4E7-4758-8D64-D5278C0DD84DQ38970692-26904E11-0BC5-418F-B450-1633D9CB373DQ39214969-E606F0CD-965B-465E-81E0-80B45952F142Q39491727-08EEA528-E82A-42CC-98B2-2A779D592BDBQ40001571-9C825A00-2E56-46B5-9C17-CAD5A2320A62Q40007128-5DB3BBC6-869C-4400-96D8-BAD32E3403F2Q40166878-851936FB-E77F-4078-A13D-CAE86BB8D7C7Q40336255-9224E180-36D2-48B7-8C09-3D0D925FD227Q40343692-212CCCD7-B7D8-40C1-9E1D-19D4DF712637Q40542458-B086D820-220B-4126-9A7F-2D72D03E9973Q40646684-E2CE6D92-0BFA-4295-AF3F-01878F73BA1CQ40961624-755E2CF7-67EA-4D01-8641-F3C0D084796AQ41054698-A1E310D6-5BBF-4FC9-B6E6-D7DCD7F54191Q41384437-5E60E87C-496D-4E8D-AFAE-676F0F8AA881Q41563253-B1D39448-7E14-4BC6-A401-2774613E6EF9Q41578261-00DF562F-EBA0-4459-A562-CBFC54DA83DAQ41633380-4481A329-3100-4F9A-A410-EF1B19FBF4B3Q41913332-66E3E65A-9EDB-441E-ACBD-D83CA1F6F28D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gabriele Missale
@ast
Gabriele Missale
@en
Gabriele Missale
@es
Gabriele Missale
@nl
Gabriele Missale
@sl
type
label
Gabriele Missale
@ast
Gabriele Missale
@en
Gabriele Missale
@es
Gabriele Missale
@nl
Gabriele Missale
@sl
prefLabel
Gabriele Missale
@ast
Gabriele Missale
@en
Gabriele Missale
@es
Gabriele Missale
@nl
Gabriele Missale
@sl
P1053
J-6083-2016
P106
P1153
7006630832
P31
P3829
P496
0000-0001-6691-8701